
A healthy kidney from a living relative replaces failed kidney function for patients with end-stage renal disease.
Quick Answer
| Procedure type | Two coordinated operations on the same admission (donor and recipient) |
|---|---|
| Anesthesia | General anaesthesia for both donor and recipient |
| Hospital stay | ICU followed by transplant ward; pairs typically remain a few weeks for follow-up |
| Recommended stay in Korea | A few weeks (individual, team-confirmed) |
| Recovery | Recipient needs lifelong immunosuppression; donor recovers from nephrectomy (usually minimally invasive) |
| Cost estimate | Itemised quote required; confirm whether donor surgery is included |
A living donor kidney transplant places a healthy kidney, donated by a living relative, into a patient whose own kidneys can no longer filter the blood.
Korea is internationally recognized for its experience and volume in living-donor transplantation, with well-established programmes built up in a setting where living donation has long been central to transplant care.
A single transplanted kidney is enough to restore filtering function, which is why one healthy person can safely donate to a relative in need.
This procedure is considered for patients with end-stage renal disease, whether from diabetes, high blood pressure, glomerular disease, polycystic kidney disease, or other causes, who would otherwise depend on long-term dialysis.
Transplant offers many patients a return to a fuller daily life and freedom from the routine of dialysis, though it is a major surgery and outcomes vary by case.
For patients travelling from Africa, the Middle East, and Asia, Korean transplant centres evaluate the recipient and the potential donor together, since the two operations are planned for the same admission.
The workup typically includes blood typing and cross-matching, tissue compatibility testing, imaging of both the recipient and the donor's kidneys and blood vessels, infection screening, and review by a team spanning nephrology, transplant surgery, anaesthesia, and coordination.
A living donor transplant has the advantage of being a planned, scheduled operation rather than an open-ended wait, and a kidney from a healthy living donor often begins working promptly.
The recipient's condition before surgery, the compatibility between donor and recipient, and the recovery that follows all influence the result, which is why the team assesses each pair individually and explains the specific risks and benefits before any decision is made.
Ethics-committee approval is mandatory before surgery
Korean transplant law requires documented proof of family relationship and ethics-committee review confirming the donation is voluntary and unpaid before any living-donor transplant can proceed. This is standard practice — prepare identity documents and relationship proof in advance so the approval process does not delay your admission date.

A living kidney donor is usually a close family member who is healthy, has two well-functioning kidneys, and is a workable match on blood type and tissue typing. Donors undergo a full evaluation, including imaging and kidney-function testing, to confirm that giving one kidney will leave them healthy.
Significant kidney disease, uncontrolled high blood pressure, diabetes, or certain infections may prevent someone from donating.
The donor and recipient must travel together and plan their stay as a pair, because both operations are scheduled within the same admission and both people recover under the same transplant team.
Korean transplant law requires a documented relationship between donor and recipient and approval from a hospital ethics committee before surgery proceeds. This protects the donor, confirms the donation is voluntary and unpaid, and is a routine, expected part of the process rather than a barrier.
Prepare identity documents, proof of family relationship, and the consent paperwork the centre will review.
Recipient candidacy depends on how stable the patient is on dialysis or before reaching it, and on whether the heart, blood vessels, and other organs can tolerate surgery and the medications that follow. Some patients need treatment to control infection, heart disease, or other conditions before transplant.
Where blood types differ, certain programmes can prepare a recipient through additional treatment; the team will tell you honestly what is possible in your case.
Living donor kidney transplant involves two coordinated operations, performed by separate teams during the same admission. In the donor, surgeons remove one healthy kidney, most often through a minimally invasive (laparoscopic) approach that uses small incisions to reduce discomfort and shorten recovery.
The kidney is removed gently to preserve its blood vessels and the ureter, the tube that carries urine.
In the recipient operation, the new kidney is placed low in the abdomen, usually without removing the patient's own kidneys unless there is a specific reason to do so.
The surgeon connects the donated kidney's artery and vein to the recipient's blood vessels, then attaches the ureter to the bladder so that urine can drain. In many cases the transplanted kidney begins producing urine soon after blood flow is restored, which the team confirms during surgery.
Both operations are carried out under general anaesthesia. The surgical and anaesthesia teams monitor blood pressure, fluid balance, and bleeding throughout, and check that the new kidney has good blood flow before closing.
The donor and recipient operations are timed closely together so that the donated kidney spends as little time as possible outside the body.
After surgery, both people are observed closely. The recipient is watched for early signs that the kidney is working well, while the donor recovers from the kidney removal.
The detailed surgical plan, including the donor's approach and the recipient's vessel connections, is tailored to the anatomy seen on imaging and is explained to both people beforehand.

Recovery proceeds in stages for both recipient and donor. Immediately after surgery, the recipient is monitored in an intensive care or high-dependency unit, where urine output, kidney function, fluid balance, and blood pressure are watched closely.
Immunosuppression medication, which prevents rejection of the new kidney, begins right away and is adjusted frequently in the first days based on blood tests.
As the recipient stabilises, they move to a transplant ward and gradually resume eating, walking, and self-care. The team continues regular blood tests to track kidney function and medication levels and watches for signs of rejection or infection, which are most likely in the early weeks.
The donor, having had one kidney removed, typically recovers more quickly, especially after a minimally invasive operation, and moves from observation to a regular ward and toward discharge as strength returns.
Many pairs stay in Korea for a few weeks after surgery so the team can confirm the kidney is settling and adjust medications before long-distance travel.
Flying home is usually considered only once kidney function is stable, wounds have healed well, immunosuppression has settled into a reliable routine, and the team judges the journey safe. This timing is individual and the centre will advise when it is realistic for your situation.
Back home, the recipient needs ongoing follow-up, regular blood monitoring, and lifelong immunosuppression managed with local doctors. Arranging that follow-up care and a steady medication supply before travel is strongly encouraged, and the Korean team can provide records to support the handover.

The price range shown for this procedure is an estimate, and the key question to confirm with the centre is whether it includes the donor's surgery and care.
Many living-donor programmes bundle the donor's operation, hospital stay, and follow-up into the overall transplant cost, but practice varies, so request an itemised quotation that states clearly what is covered for both donor and recipient and what is billed separately.
A full estimate usually includes the recipient's surgery and hospital stay, anaesthesia, post-operative monitoring, and the pre-transplant evaluation for both people, including tissue typing and cross-matching.
Costs that may sit outside the headline figure include extended hospitalisation if recovery is complicated, treatment of infection or rejection, any additional preparation needed when blood types differ, accommodation during follow-up in Korea, and travel for the donor-recipient pair.
A cost that continues long after surgery is immunosuppression medication, which the recipient takes for life. These medicines are an ongoing monthly expense to factor into long-term planning, and their price and availability in your home country are worth confirming before you travel.
Ask both the transplant centre and your local pharmacy what to expect so there are no surprises once you return home.
| Item | Typical Cost in Korea (USD) |
|---|---|
| Recipient surgery, hospital stay, and ICU monitoring | Confirm in itemised quote |
| Donor surgery, hospital stay, and follow-up | Confirm if bundled or billed separately |
| Pre-transplant evaluation — donor and recipient (tissue typing, cross-match, imaging) | Often included; confirm |
| Extended hospitalisation for complications or rejection treatment | Billed separately |
| Lifelong immunosuppression medication (ongoing, after discharge) | Not included; budget monthly |
Korea has long-established living-donor kidney transplant programmes, and several major transplant centres in Seoul perform this surgery regularly within a well-organised system of safeguards.
Korean transplant services are concentrated in large university hospitals where nephrologists, transplant surgeons, anaesthetists, and dedicated coordinators work together and support international patients through evaluation, surgery, and follow-up.
Organ transplantation in Korea operates under a clear legal and ethical framework. The Ministry of Health and Welfare sets national policy, KOIHA accredits hospitals, and Medical Korea, supported by KHIDI, assists international patients.
KONOS, the Korean Network for Organ Sharing, oversees organ donation and transplantation nationally, including the documentation and ethics-committee approval that living donation requires. These bodies exist to protect both donor and recipient and to keep the process transparent.
For patients travelling from Africa, the Middle East, and Asia, this combination of surgical experience and structured national oversight offers reassurance that the donor-recipient pair will be assessed and cared for under consistent standards.
The centres routinely coordinate with patients who are far from home and can guide the donor and recipient through the practical steps of planning a transplant abroad.
Key Takeaways
Yes. Because both operations are scheduled within the same admission, the donor and recipient travel and stay as a pair. Each person usually needs a medical-treatment visa, and the transplant centre typically provides an invitation or supporting letter for the application. Apply well ahead of the planned surgery date, since the evaluation and approvals take time, and confirm the exact visa category with the Korean embassy serving your country.
Before travelling, you will be asked to send recent records, including kidney-function tests, blood typing, dialysis history if relevant, infection screening, and reports on your general health. The centre's international coordination office usually accepts these electronically and may request translations. Sending complete records early lets the team evaluate both donor and recipient and reduces delays after you arrive.
Intensive care and high-dependency units have stricter visiting rules than regular wards, since the environment is controlled to prevent infection, which is especially important after a transplant. A companion can usually visit at set times rather than staying continuously, with broader access once you move to a transplant ward. Ask the centre about its specific ICU companion policy so your family can plan visits and accommodation.
Korean transplant law requires a documented relationship between living donor and recipient and approval from a hospital ethics committee before living donation can go ahead. This confirms the donation is voluntary, unpaid, and made by a genuine relative, and it safeguards the donor. It is a standard, expected part of every living-donor transplant rather than a sign of any problem, so prepare identity and relationship documents in advance to keep the process moving.
Flying home is considered only once kidney function is stable, wounds have healed, and immunosuppression has settled into a reliable routine, which usually means staying in Korea for a few weeks of follow-up. Immunosuppression is lifelong and must continue without interruption, so arrange local follow-up and a dependable medication supply at home before you travel. The transplant team will advise when the journey is safe for your case.
Get matched with KAHF-accredited hospitals and receive a personalized treatment plan.
Typical Cost
$40000 - $80000
Duration
21 days
Success Rate
95%+
Accredited Hospitals
0+ Available
The information provided on this page about Living Donor Kidney Transplantation is for general educational and informational purposes only. It is not intended as, and should not be construed as, medical advice, diagnosis, or treatment recommendations.
Always seek the advice of a qualified healthcare professional regarding any medical condition or treatment. Never disregard professional medical advice or delay seeking it because of information found on this website. Individual treatment outcomes may vary. Costs shown are estimates and may differ based on individual circumstances.
KmedTour acts as a medical tourism facilitator and does not provide direct medical services. All treatments are performed by independently accredited healthcare providers in South Korea.